Table 1.
Characteristics of the Mexican population with coronavirus disease 2019 (COVID-19)
| Characteristics | Overall (n = 51 053) | Men (n = 29 422) | Women (n = 21 631) |
|---|---|---|---|
| Age (y) | 46.6±15.8 | 47.1±15.7 | 45.8±16.0 |
| Duration of illness | 4.2±3.3 | 4.2±3.3 | 4.1±3.3 |
| HBP | |||
| No | 39 963 (78.3) | 23 147 (78.7) | 16 816 (77.7) |
| Yes | 11 090 (21.7) | 6275 (21.3) | 4815 (22.3) |
| Diabetes | |||
| No | 41 667 (81.6) | 23 976 (81.5) | 17 691 (81.8) |
| Yes | 9386 (18.4) | 5446 (18.5) | 3940 (18.2) |
| Obesity | |||
| No | 40 412 (79.2) | 23 625 (80.3) | 16 787 (77.6) |
| Yes | 10 641 (20.8) | 5797 (19.7) | 4844 (22.4) |
| Asthma | |||
| No | 49 463 (96.9) | 28 752 (97.7) | 20 711 (95.7) |
| Yes | 1590 (3.1) | 670 (2.3) | 920 (4.3) |
| Immunosuppression | |||
| No | 50 212 (98.4) | 28 987 (98.5) | 21 225 (98.1) |
| Yes | 841 (1.6) | 435 (1.5) | 406 (1.9) |
| Other CVD | |||
| No | 49 682 (97.3) | 28 628 (97.3) | 21 054 (97.3) |
| Yes | 1371 (2.7) | 794 (2.7) | 577 (2.7) |
| COPD | |||
| No | 49 934 (97.8) | 28 815 (97.9) | 21 119 (97.6) |
| Yes | 1119 (2.2) | 607 (2.1) | 512 (2.4) |
| Chronic kidney disease | |||
| No | 49 795 (97.5) | 28 662 (97.4) | 21 133 (97.7) |
| Yes | 1258 (2.5) | 760 (2.6) | 498 (2.3) |
| HBP and diabetes | |||
| No | 35 519 (69.6) | 20 435 (69.5) | 15 084 (69.7) |
| Yes | 15 534 (30.4) | 8987 (30.5) | 6547 (30.3) |
| HBP and obesity | |||
| No | 32 874 (64.4) | 19 187 (65.2) | 13 687 (63.3) |
| Yes | 18 179 (35.6) | 10 235 (34.8) | 7944 (36.7) |
| Diabetes and obesity | |||
| No | 33 769 (66.1) | 19 546 (66.4) | 14 223 (65.8) |
| Yes | 17 284 (33.9) | 9876 (33.6) | 7408 (34.2) |
| Smoking | |||
| No | 46 715 (91.5) | 26 232 (89.2) | 20 483 (94.7) |
| Yes | 4338 (8.5) | 3190 (10.8) | 1148 (5.3) |
| Pneumonia | |||
| No | 36 369 (71.2) | 19 857 (67.5) | 16 512 (76.3) |
| Yes | 14 684 (28.8) | 9565 (32.5) | 5119 (23.7) |
| Death | |||
| No | 45 820 (89.7) | 25 862 (87.9) | 19 958 (92.3) |
| Yes | 5233 (10.3) | 3560 (12.1) | 1673 (7.7) |
| Time from disease onset to death | 10.6±6.5 | 10.8±6.5 | 10.2±6.5 |
| Comorbidities | |||
| 0 | 27 667 (54.2) | 16 068 (54.6) | 11 599 (53.6) |
| 1 | 13 652 (26.7) | 7993 (27.2) | 5659 (26.2) |
| 2 | 6518 (12.8) | 3725 (12.7) | 2793 (12.9) |
| 3 | 2490 (4.9) | 1305 (4.4) | 1185 (5.5) |
| 4 | 572 (1.1) | 263 (0.9) | 309 (1.4) |
| 5 | 109 (0.2) | 49 (0.2) | 60 (0.3) |
| 6 | 24 (0.0) | 9 (0.0) | 15 (0.1) |
| 7 | 7 (0.0) | 5 (0.0) | 2 (0.0) |
| 8 | 14 (0.0) | 5 (0.0) | 9 (0.0) |
| Multimorbidity | |||
| 0 | 27 667 (54.2) | 16 068 (54.6) | 11 599 (53.6) |
| 1 | 13 652 (26.7) | 7993 (27.2) | 5659 (26.2) |
| 2 | 6518 (12.8) | 3725 (12.7) | 2793 (12.9) |
| ≥3 | 3216 (6.3) | 1636 (5.6) | 1580 (7.3) |
Values are presented as number (%) or mean±standard deviation.
HBP, high blood pressure; CVD, cardiovascular disease; COPD, chronic obstructive pulmonary disease.